专利检索 ap:("Nobuo Hanai" OR "Kenya Shitara" OR "Kazuyasu Nakamura" OR "Rinpel Niwa") AND inv:"Rinpel Niwa" 第 1 页

1.

发明授权
Complementarity determining region-grafted antibody against ganglioside GD3 and derivative of antibody against ganglioside GD3 失效
标题翻译：针对神经节苷脂GD3的互补决定区移植抗体及抗神经节苷脂GD3的抗体衍生物

公开(公告)号：US07253263B1

公开(公告)日：2007-08-07

申请号：US10089500

申请日：2000-09-29

申请人： Nobuo Hanai , Kenya Shitara , Kazuyasu Nakamura , Rinpel Niwa

发明人： Nobuo Hanai , Kenya Shitara , Kazuyasu Nakamura , Rinpel Niwa

IPC分类号： C12P21/08 , C07K16/00 , C12N5/06 , C12P21/04 , A61K39/395 , C07H21/04

CPC分类号： C07K16/3084 , A61K2039/505 , C07K16/18 , C07K16/28 , C07K2317/24 , C07K2317/732 , C07K2317/734 , C07K2319/00

摘要： The present invention relates to a human CDR-grafted antibody against ganlioside GD3 (hereinafter referred to “GD3”), derivatives of an anti-GD3 antibody and cytokine, and use for treatment and diagnosis of the antibody and the derivatives.

摘要翻译： 本发明涉及针对甘露糖苷GD3的人CDR-移植抗体（以下称为“GD3”），抗GD3抗体的衍生物和细胞因子，用于治疗和诊断抗体及其衍生物。